| Schedule of net deferred tax assets |  
|  |  |  |  |  |  |  |  
|  |   | As of December 31,  |  
|  |      | 2022 |      | 2021 |  
| Deferred tax assets: |  |  |  |  |  |  |  
| Net operating loss carryforwards |  | $ |  5,692,533 |  | $ |  4,586,488 |  
| Capitalized research and development expenditures |  |  |  1,873,211 |  |  |  — |  
| Stock compensation |  |   |  1,411,624 |  |   |  1,338,234 |  
| Investment in partnership |  |  |  30,771 |  |  |  30,593 |  
| Amortization |  |  |  15,223 |  |  |  16,299 |  
| Gross deferred tax assets |  |   |  9,023,362 |  |   |  5,971,614 |  
| Valuation allowance |  |   |  (8,682,497) |  |   |  (5,581,599) |  
| Net deferred tax assets |  |  |  340,865 |  |  |  390,015 |  
|  |  |  |  |  |  |  |  
| Deferred tax liabilities: |  |  |  |  |  |  |  
| Prepaid expenses |  |  |  (340,865) |  |  |  (390,015) |  
| Deferred tax liabilities |  |  |  (340,865) |  |  |  (390,015) |  
|  |  |  |  |  |  |  |  
| Net deferred taxes |  | $ |  — |  | $ |  — |   |